Aclaris Therapeutics announced an underwritten offering of common stock and pre-funded warrants totaling approximately $50 million. The offering includes 7,785,714 shares at $3.50 each and pre-funded warrants for 6,500,000 shares at nearly the same price. Proceeds will support the company's development of treatments for immuno-inflammatory diseases. The offering is expected to close on October 28, 2026, subject to customary conditions, with participation from major investors including TCGX and RA Capital Management.
Aclaris Therapeutics' recent $50 million stock and warrant offering provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 27, 2026 17:02 WIB: Of 150 priced health-sector US stocks, 60 rose and 78 fell today. Notable movers include SANA at USD 2.42 with a 1-day change of +2.54% and a typical hold time on Pluang of 25 days, AMRX at USD 20.50 down 2.47% with an 18-day hold time, and ENVB at USD 1.41 up 2.17% with a 15-day hold time.
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...
Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a new AI-powered tactical assistant designed to support naval operations by providing enhanced visualizations, automated analyses, and mission-specific recommendations. This system helps naval off...
